← Back to Search

Persuasive education for Drunk Driving

N/A
Waitlist Available
Led By Mucio Delgado
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 105 days
Awards & highlights

Study Summary

This trial will test whether behavioral and financial incentives can reduce phone use and increase seat belt adherence.

Eligible Conditions
  • Drunk Driving
  • Driving Behavior
  • Distracted Driving

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~105 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 105 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of trips with seat belt use
Secondary outcome measures
Seconds of active (handheld) phone use per hour of driving

Trial Design

4Treatment groups
Experimental Treatment
Group I: Shared pot incentive + behavioral engagementExperimental Treatment6 Interventions
Participants will receive the entire multicomponent safer driving behavioral intervention from arm 2. This arm will be identical to Arm 3, except there will be a shared pot financial incentive instead of a raffle. Participants that abstain from phone use while driving and seat belt adherence earn an equal share of prize money allocated for the entire group.
Group II: Raffle incentive + behavioral engagementExperimental Treatment6 Interventions
Participants will receive the entire multicomponent safer driving behavioral intervention from arm 2. Participants will also be eligible for the Raffle Financial incentive, where participants can earn prize money for seat belt adherence and/or no phone use while driving.
Group III: ControlExperimental Treatment1 Intervention
Participants are asked to buckle up and not engage in handheld phone use while driving. No further messaging will be provided about their behavior, and participants will not receive financial incentives for avoiding risky driving behavior.
Group IV: Behavioral EngagementExperimental Treatment5 Interventions
Participants will receive a multicomponent safer driving intervention based on behavioral science. This will include persuasive education, WOOP (mental contrasting with implementation intentions) and customized habit tips.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Persuasive education
2023
N/A
~1140
WOOP (aka, mental contrasting with implementation intentions., Wish, Outcome, Obstacle, Plan)
2023
N/A
~1140
Customized Habit Tips
2023
N/A
~1140
Raffle Financial Incentive
2023
N/A
~1140
Shared Pot Financial Incentive
2023
N/A
~1140
Weekly SMS Support text
2023
N/A
~1140
Weekly SMS Encouragement
2023
N/A
~1140

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,878,949 Total Patients Enrolled
General Motors (GM)UNKNOWN
Mucio DelgadoPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
62 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment to this trial still ongoing?

"Per information on clinicaltrials.gov, the recruitment process for this trial has closed since its posting on September 25th 2022 and subsequent update one month later. Nevertheless, there are 5 other trials currently recruiting participants at this time."

Answered by AI
Recent research and studies
~547 spots leftby Apr 2025